Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Sell
2,740
-935
-25% -$109K 0.06% 63
2026
Q1
$442K Sell
3,675
-551
-13% -$63.6K 0.09% 56
2025
Q4
$445K Sell
4,226
-50
-1% -$4.69K 0.09% 58
2025
Q3
$359K Buy
4,276
+985
+30% +$81.1K 0.08% 59
2025
Q2
$261K Hold
3,291
0.06% 65
2025
Q1
$295K Hold
3,291
0.08% 56
2024
Q4
$324K Hold
3,291
0.09% 57
2024
Q3
$374K Hold
3,291
0.1% 57
2024
Q2
$407K Buy
3,291
+600
+22% +$77.3K 0.12% 54
2024
Q1
$355K Hold
2,691
0.1% 56
2023
Q4
$293K Hold
2,691
0.09% 56
2023
Q3
$277K Buy
2,691
+62
+2% +$6.68K 0.09% 55
2023
Q2
$303K Hold
2,629
0.1% 55
2023
Q1
$280K Buy
+2,629
New +$284K 0.1% 55

Other funds holding MRK

Noble Family Wealth's MRK Position: Q2 2026 in Review

Noble Family Wealth reduced its Merck (MRK) stake by 25% in Q2 2026, selling an estimated $109K and leaving 2,740 shares worth $352K. The position accounts for 0.06% of the portfolio, ranked #63.

Noble Family Wealth first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $445K in Q4 2025. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Noble Family Wealth held 2,740 shares of Merck worth $352K as of Q2 2026.
  • Noble Family Wealth sold 935 Merck shares in Q2 2026, an estimated $109K.
  • Merck made up 0.06% of Noble Family Wealth's portfolio in Q2 2026, its #63 holding.
  • Noble Family Wealth first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • Noble Family Wealth's Merck position peaked at $445K in Q4 2025.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Noble Family Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.